{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T02:15:49Z","timestamp":1789179349563,"version":"build-2803163510"},"reference-count":36,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100015362","name":"Amicus Therapeutics Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015362","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.ymgme.2022.01.003","type":"journal-article","created":{"date-parts":[[2022,1,23]],"date-time":"2022-01-23T17:17:41Z","timestamp":1642958261000},"page":"179-185","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Early clinical phenotype of late onset Pompe disease: Lessons learned from newborn screening"],"prefix":"10.1016","volume":"135","author":[{"given":"Erin","family":"Huggins","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maggie","family":"Holland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura E.","family":"Case","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet","family":"Blount","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew P.","family":"Landstrom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harrison N.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priya S.","family":"Kishnani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2022.01.003_bb0005","author":"Hirschhorn"},{"issue":"1","key":"10.1016\/j.ymgme.2022.01.003_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ajmg.c.31324","article-title":"The new era of Pompe disease: advances in the detection, understanding of the phenotypic spectrum, pathophysiology, and management","volume":"160 C","author":"Kishnani","year":"2012","journal-title":"Am. J. Med. Genet. C Semin. Med. Genet."},{"issue":"5","key":"10.1016\/j.ymgme.2022.01.003_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpeds.2005.11.033","article-title":"A retrospective, multinational, multicenter study on the natural history of infantile-onset Pompe disease","volume":"148","author":"Kishnani","year":"2006","journal-title":"J. Pediatr."},{"issue":"3","key":"10.1016\/j.ymgme.2022.01.003_bb0020","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ymgme.2016.12.004","article-title":"The emerging phenotype of late-onset Pompe disease: a systematic literature review","volume":"120","author":"Chan","year":"2017","journal-title":"Mol. Genet. Metab."},{"issue":"1","key":"10.1016\/j.ymgme.2022.01.003_bb0025","doi-asserted-by":"crossref","DOI":"10.1186\/s13023-016-0442-y","article-title":"Childhood Pompe disease: clinical spectrum and genotype in 31 patients","volume":"11","author":"Van Capelle","year":"2016","journal-title":"Orphan. J. Rare Dis."},{"issue":"5","key":"10.1016\/j.ymgme.2022.01.003_bb0030","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/01.gim.0000218152.87434.f3","article-title":"Pompe disease diagnosis and management guideline","volume":"8","author":"Kishnani","year":"2006","journal-title":"Genet Med."},{"issue":"2","key":"10.1016\/j.ymgme.2022.01.003_bb0035","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1212\/01.wnl.0000252798.25690.76","article-title":"Broad spectrum of Pompe disease in patients with the same c.-32-13 T \u2192 G haplotype","volume":"68","author":"Kroos","year":"2007","journal-title":"Neurology."},{"issue":"4","key":"10.1016\/j.ymgme.2022.01.003_bb0040","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s00415-016-8219-8","article-title":"Survival and long-term outcomes in late-onset Pompe disease following alglucosidase alfa treatment: a systematic review and meta-analysis","volume":"264","author":"Schoser","year":"2017","journal-title":"J. Neurol."},{"issue":"2","key":"10.1016\/j.ymgme.2022.01.003_bb0045","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ymgme.2018.08.009","article-title":"Early-onset of symptoms and clinical course of Pompe disease associated with the c.-32\u201313 T > G variant","volume":"126","author":"Herbert","year":"2019","journal-title":"Mol. Genet. Metab."},{"issue":"6","key":"10.1016\/j.ymgme.2022.01.003_bb0050","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2008-3667","article-title":"Pompe disease in infants: improving the prognosis by newborn screening and early treatment","volume":"124","author":"Chien","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.ymgme.2022.01.003_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpeds.2015.10.078","article-title":"Very early treatment for infantile-Onset Pompe disease contributes to better outcomes","volume":"169","author":"Yang","year":"2016","journal-title":"J. Pediatr."},{"issue":"1","key":"10.1016\/j.ymgme.2022.01.003_bb0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1750-1172-7-73","article-title":"Effect of enzyme therapy and prognostic factors in 69 adults with Pompe disease: an open-label single-center study","volume":"7","author":"De Vries","year":"2012","journal-title":"Orphan. J. Rare Dis."},{"issue":"1","key":"10.1016\/j.ymgme.2022.01.003_bb0065","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2007-2222","article-title":"Early detection of pompe disease by newborn screening is feasible: Results from the Taiwan screening program","volume":"122","author":"Chien","year":"2008","journal-title":"Pediatrics"},{"issue":"4","key":"10.1016\/j.ymgme.2022.01.003_bb0070","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.pedneo.2013.03.009","article-title":"Pompe disease: Early diagnosis and early treatment make a difference","volume":"54","author":"Chien","year":"2013","journal-title":"Pediatr. Neonatol."},{"issue":"4","key":"10.1016\/j.ymgme.2022.01.003_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpeds.2014.10.068","article-title":"Long-term prognosis of patients with infantile-onset pompe disease diagnosed by newborn screening and treated since birth","volume":"166","author":"Chien","year":"2015","journal-title":"J. Pediatr."},{"issue":"12","key":"10.1016\/j.ymgme.2022.01.003_bb0080","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1093\/hmg\/3.12.2231","article-title":"Aberrant splicing in adult onset glycogen storage disease type II (GSDII): Molecular identification of an IVS1 (\u2212 13 T \u2192 G) mutation in a majority of patients and a novel IVS10 (+ 1GT \u2192 CT) mutation","volume":"3","author":"Hule","year":"1994","journal-title":"Hum. Mol. Genet."},{"issue":"10","key":"10.1016\/j.ymgme.2022.01.003_bb0085","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1136\/jmg.32.10.836-a","article-title":"Glycogen storage disease type II: Frequency of three common mutant alleles and their associated clinical phenotypes studied in 121 patients","volume":"32","author":"Kroos","year":"1995","journal-title":"J. Med. Genet."},{"issue":"2","key":"10.1016\/j.ymgme.2022.01.003_bb0090","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1093\/nar\/gkt987","article-title":"Functional characterization of the common c.-32-13 T > G mutation of GAA gene: identification of potential therapeutic agents","volume":"42","author":"Dardis","year":"2014","journal-title":"Nucleic Acids Res."},{"issue":"1\u20132","key":"10.1016\/j.ymgme.2022.01.003_bb0095","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jns.2008.07.013","article-title":"Cardiac evaluation in children and adults with Pompe disease sharing the common c.-32-13 T > G genotype rarely reveals abnormalities","volume":"275","author":"van der Beek","year":"2008","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.ymgme.2022.01.003_bb0100","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.jpeds.2018.02.007","article-title":"Severe cardiac involvement is rare in patients with late-Onset Pompe disease and the common c.-32-13 T > G variant: implications for newborn screening","volume":"198","author":"Herbert","year":"2018","journal-title":"J. Pediatr."},{"issue":"9","key":"10.1016\/j.ymgme.2022.01.003_bb0105","first-page":"719","article-title":"Homozygosity for the common GAA gene splice site mutation c.-32-13 T > G in Pompe disease is associated with the classical adult phenotypical spectrum","volume":"25","author":"Musumeci","year":"2015"},{"issue":"3","key":"10.1016\/j.ymgme.2022.01.003_bb0110","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ymgme.2017.09.008","article-title":"Insight into the phenotype of infants with Pompe disease identified by newborn screening with the common c.-32-13 T > G \u201clate-onset\u201d GAA variant","volume":"122","author":"Rairikar","year":"2017","journal-title":"Mol. Genet. Metab."},{"issue":"Suppl. 1","key":"10.1016\/j.ymgme.2022.01.003_bb0115","article-title":"The initial evaluation of patients after positive newborn screening: Recommended algorithms leading to a confirmed diagnosis of pompe disease","volume":"140","author":"Burton","year":"2017","journal-title":"Pediatrics"},{"issue":"Suppl. 1","key":"10.1016\/j.ymgme.2022.01.003_bb0120","article-title":"Management of confirmed newborn-screened patients with pompe disease across the disease spectrum","volume":"140","author":"Kronn","year":"2017","journal-title":"Pediatrics"},{"key":"10.1016\/j.ymgme.2022.01.003_bb0125","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jpeds.2017.06.048","article-title":"Newborn screening for lysosomal storage disorders in illinois: the initial 15-month experience","volume":"190","author":"Burton","year":"2017","journal-title":"J. Pediatr."},{"issue":"8\u20139","key":"10.1016\/j.ymgme.2022.01.003_bb0130","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.neurol.2013.07.002","article-title":"The French Pompe registry. Baseline characteristics of a cohort of 126 patients with adult Pompe disease","volume":"169","author":"Lafor\u00eat","year":"2013","journal-title":"Rev. Neurol. (Paris)"},{"issue":"4","key":"10.1016\/j.ymgme.2022.01.003_bb0135","first-page":"887","article-title":"Leaky splicing mutation in the acid maltase gene is associated with delayed onset of glycogenosis type II","volume":"56","author":"Boerkoel","year":"1995","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ymgme.2022.01.003_bb0140","first-page":"79","article-title":"Severe cardiomyopathy as the isolated presenting feature in an adult with late-Onset Pompe disease: a case report","volume":"31","author":"Mori","year":"2017","journal-title":"JIMD Rep."},{"issue":"5","key":"10.1016\/j.ymgme.2022.01.003_bb0145","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1097\/01.gim.0000217789.14470.c5","article-title":"Physical therapy management of Pompe disease","volume":"8","author":"Case","year":"2006","journal-title":"Genet Med."},{"key":"10.1016\/j.ymgme.2022.01.003_bb0150","series-title":"Motor Skills Acquisition in the First Year: An Illustrated Guide to Normal Development","author":"Bly","year":"1994"},{"issue":"1","key":"10.1016\/j.ymgme.2022.01.003_bb0155","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/ajmg.c.31320","article-title":"Assessing disease severity in Pompe disease: the roles of a urinary glucose tetrasaccharide biomarker and imaging techniques","volume":"160 C","author":"Young","year":"2012","journal-title":"Am. J. Med. Genet. C Semin. Med. Genet."},{"key":"10.1016\/j.ymgme.2022.01.003_bb0160","series-title":"JIMD Reports","first-page":"67","article-title":"Baseline urinary glucose tetrasaccharide concentrations in patients with infantile- and late-onset pompe disease identified by newborn screening","volume":"Vol 19","author":"Chien","year":"2015"},{"issue":"7","key":"10.1016\/j.ymgme.2022.01.003_bb0165","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1097\/GIM.0b013e3181a87867","article-title":"Long-term monitoring of patients with infantile-onset Pompe disease on enzyme replacement therapy using a urinary glucose tetrasaccharide biomarker","volume":"11","author":"Young","year":"2009","journal-title":"Genet Med."},{"key":"10.1016\/j.ymgme.2022.01.003_bb0170","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.ebiom.2019.03.048","article-title":"A genetic modifier of symptom onset in Pompe disease","volume":"43","author":"Bergsma","year":"2019","journal-title":"EBioMedicine."},{"issue":"4","key":"10.1016\/j.ymgme.2022.01.003_bb0175","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1177\/0022146510386794","article-title":"Patients-in-waiting: Living between sickness and health in the genomics era","volume":"51","author":"Timmermans","year":"2010","journal-title":"J. Health Soc. Behav."},{"issue":"6","key":"10.1016\/j.ymgme.2022.01.003_bb0180","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1007\/s10545-018-0159-2","article-title":"Newborn screening for Pompe disease: impact on families","volume":"41","author":"Pruniski","year":"2018","journal-title":"J. Inherit. Metab. Dis."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719222000178?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719222000178?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T23:51:04Z","timestamp":1761090664000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719222000178"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S1096719222000178"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2022.01.003","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Early clinical phenotype of late onset Pompe disease: Lessons learned from newborn screening","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2022.01.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}